The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF. Two missense variants of the DBP gene -rs7041 encoding Asp432Glu and rs4588 encoding Thr436Lys -change the amino acid sequence and alter the protein function. They are common enough to generate population-wide constitutive differences in vitamin D status, based on assay of the serum metabolite, 25-hydroxyvitamin D (25OHD). Whether these variants also influence the role of vitamin D in an immunologic milieu is not known. However, the issue is relevant, given the immunomodulatory effects of DBP and the role of protracted innate immune-related inflammation in response to tissue injury or repeated infection. Indeed, DBP and vitamin D may jointly or independently contribute to a variety of adverse health outcomes unrelated to classical notions of their function in bone and mineral metabolism. This review summarizes the reports to date of associations between DBP variants, and various chronic and infectious diseases. The available information leads us to conclude that DBP variants are a significant and common genetic factor in some common disorders, and therefore, are worthy of closer attention. In view of the heightened interest in vitamin D as a public health target, well-designed studies that look simultaneously at vitamin D and its carrier in relation to genotypes and adverse health outcome should be encouraged.
Introduction

DBP structure and function
The vitamin D binding protein (DBP), originally known as the Group-specific component (Gc-globulin), is a 51-58 kDa multifunctional serum glycoprotein synthesized in large quantities by hepatic parenchymal cells and secreted into the circulation as a monomeric mature peptide of 458 residues and three structural domains [1] [2] [3] . Two binding regions are well characterized -a vitamin D/fatty acid binding domain located between residues 35-49, and an actin binding domain positioned between residues 350-403. Recently, DBP cell surface binding sites have been localized to N-terminal and C-terminal domains (domain I and III), which may be necessary to mediate DBP cellular functions 4 . The functions of DBP are still being defined, but they include the transport of vitamin D and its metabolites in the circulation 5, 6 , as well as actin scavenging and fatty acid binding [7] [8] [9] [10] [11] [12] . Proteomic analysis shows that DBP is a hepatic acute phase reactant and is upregulated in patients with diabetes mellitus 13 , early-stage breast cancer 14 , oral squamous cell carcinoma 15 , aggressive periodontitis 16 , idiopathic temporal lobe epilepsy 17 , Alzheimer and Parkinson disease 18 and myopia 19 . It is downregulated in patients with sepsis 20 , neuromyelitis optica 21 , cutaneous malignant melanoma 22 , hepatocellular carcinoma 23, 24 , primary non-metastatic breast cancer 25 , Klinefelter syndrome 26 and type I diabetes 27 . These observations provide an attractive prospect for clinically relevant biomarker status, but further characterization is needed to establish its usefulness in patient care.
The GC gene encodes DBP DBP is encoded by the single copy GC gene (NCBI GENE ID2638) located on chromosome 4q12-q13. The genomic sequence is 35 kb in length with a single start site, 13 exons with flanking untranslated regions at both ends and a keyenhancing motif (DNase Hypersensitivity Site IV) in intron 1 ( Figure 1 ). The DBP gene is a member of a multigene family that includes albumin (ALB), a-fetoprotein (AFP), and a-albumin/afamin (AFM), tandemly linked in the following order: centromere-DBP-ALB-AFP-AFM-telomere 28 . Despite tight linkage, DBP, in an opposite direction of gene transcription, is separated from ALB by a non-transcribed sequence 1.5 Mb in length and is under autonomous regulatory control 29 .
A number of genetic variants are known (Figure 1 ). The two most common polymorphisms [c.1296T4G encoding D432E (SNPdb rs7041) and c.1307C4A encoding T436K (SNPdb rs4588)] are found in exon 11 in complete linkage disequilibrium, so only six haplotypes are observed in any significant frequency.
Genotype-phenotype associations and vitamin D metabolism
Mature serum DBP concentration is a quantitative trait with a significant hereditable component (66%), as established by twin studies published at least a decade ago 30, 31 . Functional studies of the protein polymorphisms were initiated prior to molecular identification since the three protein variants, Gc1S, Gc1F and Gc2, can be distinguished by electrophoretic migration differences 32, 33 . This is related to the differences in glycosylation pattern, resulting from replacement of the O-glycosylation moiety by a positively charged lysine residue at the T436K position as well as small differences in amino acid charge in the D432E variant ( Figure 2 ). The full functional consequences of these variants (which probably include protein half-life and cell transit times ) have not yet been delineated, although their impact on serum DBP and 25(OH)D concentrations has been demonstrated. Mean serum DBP concentrations stratified by DBP electrophorectic phenotypes were examined in 586 women 34 . Serum DBP levels did not differ between Gc1F and Gc1S alleles (D432E); however, Gc2 (T436K) showed a significantly lower level Figure 1 . Genetic variants of the vitamin D-binding protein gene (GC) . Shown in this schematic are the 13 exons (coding regions as green bars and untranslated sequences as pink boxes), separated by variable length introns (horizontal grey line, interrupted). Also shown are the DNase I hypersensitive sites (vertical red arrows). Extensively involved in control of gene expression, Site IV (HSIV), located in Intron I, is depicted in greater detail. Binding elements specific for Ccaat-enhancer-binding proteins (C/EBP, blue), GATA transcription factors (GATA, pink), hepatocyte nuclear factor 3-alpha (FoxA, lime) and nuclear factor-1 (NF-1, purple) are indicated. Besides the common missense SNPs -c.1296T4G specifying p.D432E, and c.1307C4A specifying p.T436K -there are a number of other well documented (black) and novel (orange) single-nucleotide variants scattered throughout the gene of relevance to future genetic association studies. compared with Gc1 (Gc1F and Gc1S combined) (p ¼ 0.001). The highest DBP serum concentration was in Gc1-1 subjects (272 AE 2 mg/L), the lowest in Gc2-2 (226 AE 2 mg/L) and intermediate levels were found in heterozygous subjects (249 AE 3 mg/L) 34 . Other investigators have confirmed these findings 30, 35 . Similarly, our study also confirmed that the lowest serum DBP concentration was in the subjects with 436KK genotype (encoding the Gc2-2 protein variant) 36 . Conclusions based on this type of candidate gene approach have been confirmed and strengthened by the results of genome-wide association studies (GWAS). In populations of European ancestry, two independent studies found that an intronic SNP rs2282679 which is in tight linkage disequilibrium with D432E had the strongest genome-wide significant associations with 25(OH)D concentrations 37, 38 . As noted before, the physiological relationship between the genetically determined differences in circulating DBP molecules and overall DBP concentrations is uncertain, but it seems likely that they specify not only the D432E and T436K substitutions in the peptide, but also affect glycosylation status 39, 40 , and consequently, macrophage stimulating activity. While these common polymorphisms are associated with DBP status, others have demonstrated association between genotype and serum vitamin D metabolite levels.
A recent study examining a cohort of 595 Danish Caucasian menopausal women showed that after adjusting for confounders, DBP phenotype is an independent predictor of 25(OH)D (p ¼ 0.016) 41 . Similar analysis of a large Han Chinese cohort (n ¼ 3210) found four SNPs at the GC locus (D432E, T436K, rs2282679 and rs1155563) significantly associated with lower plasma 25(OH)D 42 . Of note, is the finding that T436K and rs2282679 remained significant after adjusting for the other two SNPs. A cross-sectional study examining 741 premenopausal white women of FrenchCanadian descent demonstrated that each additional copy of the 432D or 436 K alleles reduced 25(OH)D concentrations significantly (p50.0003 and p50.0001, respectively) 43 . Similarly, in a study population of 98 healthy adult women, we found that the 436KK homozygotes exhibited reduced baseline vitamin D serum levels 44 . Of more immediate clinical interest, perhaps, was our observation that this allele was also correlated with the response of serum 25(OH)D levels to long-term vitamin D supplementation. The subjects with 436KK genotype showed the largest proportional increase in response to a vitamin D supplement. The population-wide implications of these findings for vitamin D in public health are substantial, given that Figure 2 . Common electrophoretic variants of the Gc protein (DBP). Shown at the top is the relative electrophoretic separation of the various Gc species, based on their isoelectric points (pI). The corresponding molecular structures are given below that. Only five residues of primary amino acid sequence (residues 432-436 ¼ Asp-Ala-Thr-Pro-Thr ¼ D-A-T-P-T) are depicted, along with their O-linked saccharides. Note that the D432E mutation results in a very small separation (DpI ¼ 0.01), since the carboxyl side chains of the wild-type aspartate residue (in the Gc1F species) and the mutant glutamate residue (in Gc1S) have such similar dissociation constants. There is larger separation of the two Gc1 species if the negatively charged sialic acid residue (generating the anodal form, Gc1a) is removed, generating Gc1c, the cathodal form. Gc-MAF, shown at the bottom, arises as a result of sequential deglycosylation removing first the sialic acid and then the galactose residues. At the T436 position, the genetic variant Gc2 shows a more marked cathodal shift in electrophoretic migration due to replacement of the O-glycosylation site by a positively charged lysine residue (436 K).
the 436 K allele is less prevalent in Africans (15%) than in Caucasians (23%), Hispanics (20%) or Asians (29%) 45 . Indeed, we have recently shown that this is mirrored in immigrant sub-populations found in large North American cities 46 .
Vitamin D, DBP and innate immunity -an emerging theme
The role of DBP in the biology of vitamin D as it relates to the endocrine status of bone and mineral metabolism is well established and the reader is referred to reviews 47, 48 , monographs 49 and authoritative web sites 50 . DBP is thought to regulate the bioavailability of 25 52 . Moreover, epidemiologic evidence for mitigating chronic diseases such as cancer 53 , and for upregulation of antimicrobial peptide synthesis 54, 55 applies to both vitamers.
Interestingly, DBP has also been shown to play a more direct role in the inflammatory cascade by enhancing the leukocyte chemo-attractant effect of compliment activation peptide C5a, one of the most potent of the early-acting chemo-attractants [56] [57] [58] [59] [60] . The role of DBP as a C5a adjuvant is apparently not strictly vitamin D independent as 1,25(OH) 2 D 3 can mitigate the synergistic effect of DBP and C5a 60 . The stepwise glycohydrolysis promoted by T and B cells leads to loss of the O-glycosylated oligosaccharide moiety in the DBP peptide, transforming it into a potent macrophage activating factor (Gc-MAF) 61, 62 . Finally, while DBP plays a proximate role in innate immune regulation, it may also act more distantly through actin scavenging to protect the host from the effects of cell damage due to tissue ischemia, inflammation or mechanical injury. Whereas excessive globular actin released from damaged cells can cause intravascular coagulation resulting in multi-organ dysfunction and cardiac arrest, DBP functions to bind and sequester actin in circulation released from damaged cells, thus potentially mitigating adverse outcomes of tissue injury 7, 11, 63, 64 . The various roles that DBP plays in different inflammatory processes suggests that functional polymorphisms in the DBP gene, GC, may therefore predict adverse outcomes in a wide range of chronic and infectious diseases associated with these processes. Below we summarize the evidence supporting this contention, and examine the strength of the findings to date (Table 1) .
DBP genotypes and chronic disease
Diabetes
Type I diabetes mellitus results from the autoimmune destruction of insulin producing pancreatic b-cells while type II diabetes is associated with insulin resistance and elevated levels of inflammatory mediators 65, 66 . Vitamin D may play a role in the prevention and treatment of diabetes through its anti-inflammatory actions or by modifying calcium homeostasis to improve insulin secretion or enhance insulin sensitivity 67 . As such, polymorphisms in the DBP gene might provide insight into the role of vitamin D and diabetes.
Several studies have examined whether pre-diabetic phenotypes are associated with DBP variants. In a Japanese study group, composed of 47 males and 35 females with normal glucose tolerance, carriers of Gc1S-2 and Gc1S-1S had significantly higher fasting plasma insulin levels than homozygotes for Gc1F (p50.01 and p50.03, respectively) 68 . These findings were supported in an ethnically distinct population made up of 144 Dogrib Indians of the Northwest Territories in Canada 69 . On the other hand, Baier et al. found no association with insulin or fasting plasma glucose concentrations in a Pima cohort, although they did report that exon 11 polymorphisms were associated with blood glucose responses to an oral glucose challenge in non-diabetics 70 . Specifically, individuals homozygous for Gc1F had the highest increment in glucose concentration at 30 and 60 min and the lowest glucose concentration at 180 min. Moreover, carriers homozygous for Gc2 had significantly lower mean incremental glucose concentrations at 60 and 120 min 70 . Similarly, in a population-based case-control study composed of Hispanic and Anglo participants from the San Luis Valley Diabetes Study, DBP variants were not associated with insulin levels 71 . Also, and in contrast with Baier et al., DBP variants were not associated with postprandial glucose, but were associated with fasting glucose levels (F ¼ 2.46; p ¼ 0.033), the Gc1F genotype being more commonly observed in individuals with the highest levels of plasma glucose 71 .
Other studies have examined the association between genetic variants of DBP and clinical diabetes. Results from a Japanese study, composed of 208 non-insulin-dependent diabetes mellitus patients and 209 control subjects with normal glucose tolerance, showed that Gc1F-1F homozygosity was less frequently and Gc1S/2 heterozygosity more frequently observed in patients compared to controls (p50.001 and p50.02, respectively) 72 . Sequence analysis identified D432E and T436K genotypes in a cohort of 912 Pima Indians (578 diabetic; 334 nondiabetic) from Gila River Indian Community in Arizona, USA 70 , but no association was reported between either variant and the prevalence of type II diabetes.
In a family-based study, the tetranucleotide repeat in intron 8 73 and D432E and T436K polymorphisms were studied in 152 Caucasian families of German origin with at least one child developing type I diabetes 66 . Transmission disequilibrium testing (TDT) showed neither allelic distortion of intron 8 or exon 11 alleles between cases and controls, nor of their In these studies, ethnicity was not clearly provided so they are assumed to be representative of the ethnic majority of the country where the study originates. 74 . These findings were substantiated in French and Polish Caucasian case-control studies that additionally reported that phenotypes, defined by haplotype combinations, were equally distributed between Type II diabetics and non-diabetics 75, 76 . In aggregate, these studies fail to support a strong, consistent role for DBP in the pathobiology of diabetes. It is likely that ethnicity and lifestyle factors contribute to the lack of concordance among these studies.
Osteoporosis
Osteoporosis is a common disorder of aging that disproportionately affects post-menopausal women. It is characterized by low bone mass and micro-architectural changes in bone which contribute to increased bone fragility and risk of fracture 77 . The primary clinical marker of osteoporosis, lower bone mineral density (BMD), is associated with vitamin D insufficiency [78] [79] [80] . However, the links between DBP and bone biology are not well understood. Whereas Gc-MAF is shown to increase phagocytosis and free radical (superoxide) production in macrophages 61, 81 , further work has implicated it as a potent activator of osteoclasts 82 . Indeed, osteopetrotic patients (characterized by excessively dense bone and high BMD) appear to lack the ability to generate Gc-MAF 83 . Osteopetrotic rats treated with Gc-MAF showed a reduction in BMD and associated skeletal defects 84 . In the ongoing 20-year Danish Osteoporosis Prevention Study comprised of 595 white postmenopausal women, Scandinavian investigators found a three-fold lower fracture risk associated with Gc2-2 compared with Gc1-1 genotype (p ¼ 0.014, OR ¼ 0.32, 95% CI ¼ 0.13-0.80) 77 . A more comprehensive set of SNPs distributed across promoter, intronic and exonic regions of DBP was analyzed in 384 Japanese in a search for association with BMD 85 . Six SNPs (À39C4T, IVS1 þ 827C4T, IVS1 þ 1916C4T, IVS1-1154A4G, D432E and IVS11 þ 1097G4C) were either significantly associated or suggestively associated with BMD, the IVS11 þ 1097G4C SNP in intron 11 showing the strongest correlation (p ¼ 0.006). Furthermore, a common haplotype (T-C-C-G-T-C) derived from the six SNPs showed significant association with adjusted radial BMD (r ¼ 0.15, p ¼ 0.008). The functional consequence(s) of these SNPs/haplotypes are not known.
Another polymorphism in the form of an (TAAA) n -Alu repeat or repetitive element downstream of intron 8 was examined in a cohort of Caucasian men from northeast England for association with DBP serum levels, BMD and osteoporosis 86 . The (TAAA) 8 (GC-I8*8) allele is the most prevalent one in this study group. Upon analyzing 26 men with vertebral fractures and 21 controls, the GC-I8*10/*8 genotype was found to be associated with decreased BMD lumbar spine and femoral neck BMD and increased vertebral fractures compared with GC-I8*10/*10 (p50.05, OR ¼ 56; 95% CI ¼ 7-445) 86 . Interestingly, GC-I8*10/*8 was also associated with elevated serum DBP (p ¼ 0.049) which, in turn, may provide greater potential for Gc-MAF activation of osteoclasts in Gc1 carriers. Results of this study remained consistent in another male cohort made up of 56 individuals with idiopathic osteoporosis and 114 controls, but the odds ratio was much more modest 87 . Carriers of the GC-I8*10/*8 genotype and the GC-I8*9 allele were at increased risk of osteoporosis (OR ¼ 2. 88 In a common aging disorder like osteoporosis, many genes are involved and interaction with non-genetic factors (e.g. calcium and vitamin D intake) is common. A recent prospective study examining more than 6100 elderly Caucasians found no association between DBP phenotype and osteoporosis; however, a 33% increased risk of fracture was detected in Gc1S carriers homozygous for polymorphisms in the 3 0 untranslated region (UTR) of the vitamin D receptor (VDR) in haploblock 5 compared with non-carriers (p ¼ 0.005) 88 . Moreover, a hazard ratio of 1.47 (95% CI ¼ 1.06-2.05) was observed for homozygous Gc1S carriers (compared with non-carriers) with low dietary calcium intake (51.09 g/day).
Collectively, these studies emphasize the importance of gene-gene and gene-environment interactions in complex trait analysis and underscore the need to characterize the role of non-coding genetic variants associated with osteoporosis and related phenotypes.
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is characterized by decreased pulmonary elastic recoil, expiratory obstruction and hyperinflation secondary to inflammation of peripheral airways 89 . The role of DBP as a modulator of inflammation suggests that it plays a role in the chronic pulmonary inflammation characteristic of COPD. Consistent with this hypothesis, an association study in a Caucasian population of 104 COPD patients and 413 controls indicated that Gc1F-1F and Gc1S carriers (at least one copy) were seven-fold and two-fold more likely, respectively, to have COPD than individuals with at least one Gc-2 allele 90 . In another study of 75 Caucasian COPD patients, Gc-2 homozygosity was found to be underrepresented in COPD patients compared to 64 controls (OR ¼ 0.17, CI ¼ 0.03-0.83) 89 . This is in agreement with an earlier report examining 114 COPD cases in a match pair design study showing an excess of Gc2 homozygotes in the control group (p ¼ 0.049) 91 . Similarly, a recent study of 471 unrelated Caucasian subjects confirmed that the Gc2 variant was associated with a decreased risk of COPD (OR ¼ 0.79, CI ¼ 0.65-0.99; p ¼ 0.048), though it was associated with an increased risk of bronchiectasis in patients with a1-antitrypsin deficiency (OR ¼ 1.51, CI ¼ 1.02-2.22) . The authors suggested this may be due to reduced capacity to produce Gc-MAF, thereby stimulating macrophage-induced pathogen clearing from the airway 92 . A Japanese case-control study (103 cases, 88 controls) found that Gc1F homozygotes were more susceptible to chronic bronchitis and emphysema due to COPD than were healthy smokers (p ¼ 0.01, OR ¼ 2.3, 95% CI ¼ 1.2-4.6) 93 . In a second Japanese cohort, Gc1F homozygotes were overrepresented among COPD patients (36.5%) compared to controls (20.7%; OR ¼ 2.2; 95% CI ¼ 1.1-4.6). However, no association was found with diffuse panbronchitis, also characterized by chronic airflow limitation 94 . In a case-control study of a Han Chinese cohort (100 cases, 100 controls), the COPD patient group was found to be enriched for Gc1F homozygous individuals while the frequency of Gc2 was significantly lower 95 . Together, these findings are consistent with evidence suggesting that the presence of the 436 K minor variant (Gc2) precludes the conversion of DBP to Gc-MAF, potentially reducing macrophage-related inflammation 96 . Another recent report indicates that, 25(OH)D deficiency is more common in COPD patients from Belgium and correlates with disease severity 97 . In the same study, homozygous T436 subjects were found to have a 25% reduction in vitamin D serum levels (p50.0001) and were enriched amongst the COPD patient population (OR ¼ 2.11; CI ¼ 1.20-3.71). It is conceivable, therefore, that anti-inflammatory actions exerted downstream of 25(OH)D 52, 97 are reduced in patients. The nature by which DBP influences COPD pathogenesis deserves further investigation, however unlikely it is to affect the rate or onset of deteriorating lung function 98, 99 .
Asthma
Asthma is a chronic inflammatory condition characterized by airway obstruction and elevated serum IgE levels 100 , most often found to be a consequence of enhanced acquired reactions to external allergens. It is associated with various reactive pro-inflammatory states including allergic rhinitis and eczema. Ecological studies indicate that vitamin D deficiency is associated with asthma and asthma related phenotypes [101] [102] [103] [104] [105] , but some studies contradict these findings reporting a positive association 106, 107 , whereas others show no association 108 . Further evidence suggesting an inverse correlation between vitamin D and asthma is provided by genetic 109, 110 and epidemiologic (geospatial and solar radiation) studies 111 . However, in another study, Hughes et al. reported no association between ultraviolet radiation (UVR) or vitamin D serum levels; yet, cod liver oil supplementation earlier in life was associated with an increased risk of asthma 112 . Overall evidence suggests that vitamin D protects against asthma, but the precise nature of this relationship is ambiguous and inconsistent findings are likely a function of epidemiological context. A molecular mechanism by which vitamin D may affect asthma is unknown and its relationship to atopy is unclear. However, emerging evidence suggests that 1,25(OH) 2 D 3 inhibits Th2-related asthmatic inflammation either directly or via immunosuppressive T-regulatory cell induction [113] [114] [115] . However, these findings were not substantiated in a recent case-control study examining 467 asthmatic patients and 288 unrelated healthy controls in a Chinese Han population, which showed an enrichment of Gc2-2 in asthma cases (OR ¼ 1.35: CI ¼ 1.01-1.78; p ¼ 0.006) 116 . A TDT of more than 200 families from the German Asthma Family Study found no significant association with asthma, but rs222040 and rs7041 (D432E) were both weakly associated with total serum IgE (p50.02 and p50.03, respectively) 117 .
Ischemic stroke
Risk of ischemic stroke is associated with elevated levels of vascular inflammation 118, 119 and lower 25(OH)D 120 , both of which are thereby linked to DBP. In six study populations from the United States, Europe and China (3550 cases, 6560 controls), a recent study evaluated 105 variants in 64 inflammation-and cardiovascular-related genes for association with ischemic stroke. Among the SNPs evaluated were DBP D432E and T436K, but neither was significantly associated 119 .
Endometriosis
Endometriosis is a uterine disorder in which large overgrowths of endometrium accumulate inside or adjacent to the uterus 121 . The precise etiology remains unclear, but one theory holds that the peritoneal epithelia can differentiate into endometrial tissue as a result of chronic inflammation 122 . Furthermore, macrophage activation has been associated with disease progression 123 , thereby highlighting a potential role for DBP. In a recent cross-sectional study of premenopausal women undergoing laparoscopy, analysis of specific Gc allele products using nano-scale liquid chromatography-electrospray ionization-mass spectrometry indicated that the Gc-2 allele product was enriched in serum samples in women with endometriosis (p ¼ 0.006) 124 . The authors speculate that the lack of activated macrophages' phagocytic function in those Gc2 carriers may increase the risk for implantation of endometriosis tissue in the peritoneal cavity. Further investigation of this hypothesis is warranted.
Inflammatory bowel disease
Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis, both of which are characterized by chronic inflammation of the gastrointestinal tract 125 . Data collected as part of the Swiss Inflammatory Bowel Disease Cohort Study was used to test for associations between common DBP polymorphisms and risk of IBD 125 . Homozygotes for the K allele of T436K SNP were more common in non-IBD controls than in IBD patients (p ¼ 0.006). Significant associations were observed between SNP variants and disease risk in separate comparisons of healthy controls with ulcerative colitis (p ¼ 0.022) and Crohn's disease patients (p ¼ 0.016) 125 . The DBP-2 haplotype (consisting of D432-436 K) was found at higher frequencies in healthy controls than in IBD cases (OR ¼ 2.53, CI ¼ 1.48-4.34, p ¼ 0.0005), especially when comparing healthy controls to the ulcerative colitis cases (OR ¼ 4.39, CI ¼ 1.87-10.31, p ¼ 0.0003).
Cancer
Several observational studies have demonstrated an inverse relationship between UVB irradiance (required for the 126 , lung 127, 128 , breast 127, [129] [130] [131] [132] [133] , prostate [134] [135] [136] [137] , ovarian 138, 139 and colorectal cancer [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] . The underlying mechanism by which vitamin D status affects cancer risk is unknown, however, 1,25(OH) 2 D 3 has been shown to modulate cell proliferation and differentiation of both normal and malignant cells. Alternatively, inflammatory modulation effects of 1,25(OH) 2 D 3 or Gc-MAF may play important roles in cancer pathogenesis.
Breast cancer
Ecological case-control studies indicate an inverse correlation between vitamin D status and breast cancer risk, however, the relationship is less clear in longitudinal studies 150, 151 . Much work has been done to elucidate a vitamin D-related mechanistic role in breast cancer. Gc-MAF exhibits antibreast tumor activities in mice 152 and shows immunotherapeutic properties in metastatic breast cancer patients 153 . Exposure to Gc-MAF significantly reduces vimentin expression in human breast cancer cells, suggesting a reversal of breast cancer progression 154 . Alternatively, the active metabolite of vitamin D, calcitriol, has been shown to inhibit cell proliferation and differentiation and promote apoptosis of breast tumor tissue [155] [156] [157] [158] . Genetic studies examining the relationship between functional DBP variants and breast cancer (in situ and invasive) have yielded inconsistent findings. In a nested case-control study derived from the Cancer Prevention Study II Nutrition Cohort (500 cases, 500 controls), D432E and T436K were not associated with postmenopausal breast cancer risk 159 . Interestingly, a German population-based case-control study comprised of 1,402 post-menopausal women with in situ or invasive breast cancer and 2608 population controls reported a protective effect of Gc2-2 carriers (OR ¼ 0.72, 95 % CI ¼ 0.54-0.96) 160 . Both these studies argue against a role for Gc-MAF or vitamin D in breast cancer pathogenesis. In contrast, subjects with the rs7041 TT genotype were at increased risk of breast cancer (OR ¼ 1.23; 95% CI ¼ 1.01-1.51) based on a study of 1560 invasive breast cancer patients and 1633 controls from the Ontario Women's Diet and Health Study 161 . Altogether, these findings underscore the complex pathogenesis of breast cancer and highlight the need to consider gene-environment interactions.
Prostate cancer
Studies have shown that vitamin D can inhibit proliferation and differentiation of human prostatic cells in vitro 162 and 1,25(OH) 2 D 3 has marked anti-tumor effects in animal models 163 . Furthermore, recent work has demonstrated that Gc-MAF directly inhibits proliferation and migration of prostate cancer cells as well as expression of a tumor metastasis-associated gene, urokinase plasminogen activator receptor 164 consistent with an early study demonstrating the elevated risk of Gc2 genotype and carcinoma of the prostate 165 . However, in a comprehensive study of 749 cases and 781 controls from the PLCO Cancer Screening Trial, Ahn et al. found no association between risk of prostate cancer and 15 SNPs in GC, which included D432E and T436K
166 . An earlier study examining D432E and T436K in 181 prostate cancer patients (90 black and 91 white) and sex-, age-and race-matched controls also found no differences in allelic/genotypic frequencies between patients and controls; however, frequencies were strikingly different between blacks and whites 167 . 
Gastrointestinal and colorectal cancer
Skin cancer
Associations between GC SNPs and basal cell carcinoma (BCC) were examined as part of the prospective cohort Rotterdam Study (n ¼ 7983). The study found no significant association between the GC genotypes and haplotypes and risk of developing at least one BCC. However, Gc1F carriers were more likely to develop a first BCC compared to noncarriers (HR ¼ 1.40; 95% CI ¼ 1.11-1.78). When stratified by age, individuals younger than 65 years of age and homozygous for Gc1S had about half the risk of developing a first BCC, compared to non-carriers (HR ¼ 0.53; CI ¼ 0.31-0.91) 171 .
Neurodegenerative disorders
Multiple sclerosis
Multiple sclerosis (MS) is a form of disseminated encephalomyelitis that appears to be partly autoimmune in origin though its etiology is not known. The rates of MS exhibit a pattern of increasing prevalence with increasing latitude, indicating a protective role of ultraviolet radiation in the development of MS 172 . Moreover, several studies have shown an inverse correlation between serum levels of vitamin D and MS 173, 174 , suggesting that polymorphisms influencing vitamin D status might contribute to the initiation or progression of disease.
Serum DBP was found to be upregulated along with other acute phase reactive proteins in a small sample (n ¼ 9) of pediatric MS patients 175 , however, the clinical relevance is not known. Early reports examining the distribution of DBP phenotypes among European adults did not find significant correlations with presence of disease, disease natural history or age of onset 176, 177 . Similarly, in 107 Japanese MS patients and 109 controls, neither DBP phenotypes nor D432E/T436K genotypes (examined independently) were associated 173 , a finding that was recently confirmed 178, 179 . To control for population admixture/stratification, both SNPs were evaluated in a family-based design study of 187 Canadian families; however, the lack of association between genotype and disease was unchanged 174 . Ongoing interventional trials with vitamin D and association studies with larger cohorts may offer further opportunity to explore an interactive role of DBP SNPs with vitamin D in MS.
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is another neuropathy of unknown etiology that is characterized by the progressive loss of motor neurons in the brain and spinal cord, leading to debilitating, usually fatal, muscle atrophy 180 . While the vast majority of ALS patients are sporadic, 10-15% of cases show familial clustering. Mutations in the cytosolic superoxide dismutase (SOD1) gene have been associated with ALS, but these account for less than 20% of all familial ALS (FALS) 181 . In Portuguese patients with FALS, proteomic analysis showed that the Gc-2 phenotype (436 K) was overrepresented in comparison to healthy controls 182 . The role of DBP in ALS is not known, but it is tempting to speculate that motor neuron damage resulting in the systemic release of actin and ensuing intravascular coagulation and local hypoxia-induced oxidative damage may be mitigated by the actin-scavenging properties of DBP. Whether the apparently reduced capacity of Gc-2 for actin-scavenging, compared with Gc1 30, 34, 35 , might increase the likelihood of disease progression is not known.
Schizophrenia
A number of hypotheses have been put forth to explain the etiology of schizophrenia, but several lines of observational evidence suggest that vitamin D may be a risk factor 183 . The underlying molecular mechanism governing this association is not known, but prenatal vitamin D deficiency is associated with structural and functional deficits common to schizophrenic patients. Several early reports examined DBP phenotypes in relation to schizophrenia. An excess of Gc1-1 was observed in cases over controls in a study carried out in a German study (p50.01) 184 . This association was even more compelling for the hebephrenic subgroup (p50.01). On the other hand, analysis of a north east England cohort comparing 215 schizophrenic patients with healthy first-degree relatives or non-familial controls reported a significant reduction in Gc1S alleles (p ¼ 0.025) largely within the female subjects 185 .
Findings from a Chinese male cohort of 423 schizophrenic patients also suggested a relative paucity of Gc1S (p50.001) and an excess of Gc2 186 . However, there are several other studies reporting lack of association between DBP and schizophrenia [187] [188] [189] , and firm conclusions would be premature.
Parkinson disease
Parkinson disease is a progressive movement disorder, the severity of which has been found to be inversely associated with serum levels of 25(OH)D 190 . However, a study examining GC polymorphisms and severity of Parkinson disease did not identify any significant associations 191 .
Other chronic diseases
Liver disease
In liver disease, secretion of proteins belonging to the albumin family is usually reduced, and it is therefore not surprising that there are numerous studies reporting lower serum DBP concentrations in this group of disorders. This may also be associated with inability to sufficiently sequester cellular actin released by the dying hepatic cells themselves, thereby contributing to an increased risk of intravascular coagulation. Variants associated with DBP status might therefore be useful as biomarkers of worse outcomes in liver disease. Looking at 17 alcoholic liver cirrhosis patients and 100 healthy controls, French investigators observed an unusual electrophoretic form of non-ligand bound DBP that was characterized by the presence of an additional sialic acid moiety. This form of DBP was found only in Gc-1 carriers and was associated with worse clinical outcome 35 . To date, this novel phenotype has not been reported in other studies and, therefore, the larger relevance in non-hepatic disorders is unknown.
Sarcoidosis
Sarcoidosis, a granulomatous inflammatory disease, typically affects young adults and is associated with altered immunoglobulin and increased 1,25(OH) 2 D 3 production. DBP phenotypes were examined in a small case-control study of 88 patients, but found no relationship between disease, course of disease, or presentation 192 . Whether 1,25(OH) 2 D 3 levels might be associated with the D432E or T436K genotypes, as others have observed, was not studied.
Thyroid autoimmune disease
Graves' disease and Hashimoto thyroidosis are the two common forms of autoimmune thyroid disease. In such disorders, 1,25(OH) 2 D 3 downregulates expression of thyrocyte-derived human leukocyte antigen class II molecules 193 and inhibits secretion of proinflammatory cytokines and lymphocyte proliferation 194 . In 95 and 92 Western European pedigrees positive for Graves' disease and Hashimoto's thyroiditis, respectively, Pani et al. looked at TDT of the DBP gene 195 . Only the Alu repeat in intron 8 (I8*8) was found to be associated with Graves' disease (p50.03), and none were associated with Hashimoto's thyroiditis. Neither D432E nor T436K was associated with disease outcome. In contrast, association of GC SNPs with Graves' disease was found in a case-control study evaluating 332 cases and 185 healthy controls of Polish origin. In that study, cases were significantly enriched for the T436K heterozygotes (OR ¼ 1.50; CI ¼ 1.13-1.99; p ¼ 0.005) 196 .
Infectious diseases
Tuberculosis
Mycobacterium tuberculosis, the causative agent of tuberculosis, infects a third of the world's population and results in 3 million deaths per year 197 . Low serum levels of 25(OH)D have been correlated with extant tuberculosis [198] [199] [200] [201] [202] [203] [204] and incident infection 204 . Oral supplementation of vitamin D given to tuberculosis contacts enhanced immunity towards the mycobacterium 205 . A significant advance in our understanding of innate immunity against tuberculosis came with a seminal report showing convergence of the vitamin D metabolic pathway with the Toll-like receptor (TLR2/1) signaling cascade resulting in the induction of cathelicidin, a potent antimicrobial peptide in the innate immunity pathway 54, 55 . Subsequently, GC genotypes were examined in several ethnically diverse tuberculosis study populations 206 . In Gujarati Asians, the homozygous variant Gc2-2 phenotype was strongly associated with susceptibility to active tuberculosis, compared with Gc1-1 using logistic regression to adjust for age and sex (OR ¼ 2.81, CI ¼ 1.19-6.66, p ¼ 0.009). Furthermore, this association was observed only under conditions of low 25(OH)D, suggesting an important geneenvironment interaction in this condition.
Rheumatic fever
Rheumatic fever is a systemic inflammatory illness characterized by excessive B cell activity leading to an overproduction of antibody to Group A streptococcus. DBP is found on the surface of B-cells, often in a molecular complex with actin and surface immunoglobulin, and may play a role in B cell activation by facilitating signal transduction activity 207 . Alternatively, inflammatory mediation of DBP may affect the course of disease. In a study of 39 cases and 90 controls of Arab ancestry, a positive association between the Gc-2 allele and rheumatic fever was observed (p ¼ 0.0024) 208 . The implications of this finding are not altogether clear, but suggest that the anti-inflammatory properties of Gc-2 may not be important in this disorder.
Human immunodeficiency virus
Untreated, human immunodeficiency virus (HIV) infection often progresses to acquired immunodeficiency syndrome (AIDS) with its subsequent complications of opportunistic infection and neoplasia. Macrophages are among the first cell types to be infected by HIV-1 and serve as reservoirs for the virus in affected persons 209, 210 . Macrophage activation via Gc-MAF may therefore be an important factor in the acquisition of HIV-1 infection and progression to AIDS. Indeed, immunotherapy of HIV-infected individuals with GcMAF appeared to be significantly curative 211 . Several studies have examined the association between DBP variants and HIV/AIDS. DBP phenotypes were examined in a cohort consisting of 86 HIV negative hospital workers, 351 homosexual men that were either HIV negative (as determined by the absence of HIV antibodies) or HIV positive (as determined by the presence of HIV antibodies with or without HIV antigen), and 96 AIDS cases 212 . It is thought that the presence of HIV antigen is a strong predictive marker of disease progression [213] [214] [215] . During the course of this study, a subset of 62 HIV negative homosexual men seroconverted. No significant difference in DBP distribution was observed between HIV negative heterosexuals, HIV negative homosexuals and patients with AIDS. Moreover, there was no difference in DBP phenotype distribution between homosexual men who remained HIV negative and those who sero-converted during follow-up, arguing against the involvement of DBP in susceptibility to HIV infection. Finally, DBP phenotypes were equally distributed among (i) HIV-positive homosexuals without the presence of HIV-antigen, (ii) HIV positivity with the presence of HIV antigen and (iii) AIDS -effectively excluding a role for DBP in either susceptibility or progression. Other investigators examining Spanish, German and Swedish populations also found no evidence of association between DBP variants and susceptibility to HIV/AIDS [216] [217] [218] . However, an excess of Gc2 was observed in persistently seronegative sexual contacts (engaging in unprotected sex) of AIDS patients, although the sample size was small 219 . In summary, there is little evidence to support a role for DBP in susceptibility to HIV/AIDS or progression to AIDS, based on these studies. The interplay between HIV and DBP, however, is complex 211 and likely confounds any true associations between genetic variation and infection/disease outcome. Investigators may choose to focus on identifying new genetic variants in or near the GC gene that may provide further insight into a molecular mechanism bridging DBP and HIV/AIDS.
Discussion
We present an overview of studies examining the association of genetic/phenotypic variants of GC and adverse health outcomes, several of which constitute global health problems of major public health importance. It is becoming increasingly evident that the DBP plays an important role in inflammation and immunity, and that genetic variants encoding this protein may, in part, modulate these pathophysiologic pathways. Despite recent progress, the nature of this regulation remains unclear. In comparison to Gc-2 (436 K) types, non-Gc-2 polymorphisms are associated with increased macrophage activity and elevated vitamin D serum levels required for downstream upregulation of antimicrobial peptides 220 . While it is tempting to speculate that Gc1-related macrophage activity results in prolonged inflammation associated with chronic diseases 61 , binding of active 1,25(OH) 2 D 3 metabolite to its intracellular receptor (VDR) is antiinflammatory 52, 221 . Included amongst those actions is the negative regulation of nuclear factor kappa B (NFB), an essential component of the inflammatory response by recruitment of histone deacetylase 3 52, 222 . It should be noted that there are inherent limitations in some association studies that are related not to sample size but to intrinsic heterogeneity of disease phenotype. A case in point is schizophrenia, a disorder that is notoriously difficult to classify and has proven quite resistant to confirmation of initially promising results 223 . Candidate gene studies looking at DBP in this area are no exception.
Further work is needed to characterize more precisely the role of DBP in chronic and infectious disease, however, current evidence from genotype-phenotype association studies does indicate an important role in innate-immune-related inflammation.
Conclusion
There is growing evidence that DBP plays a role in immune modulation, either directly through Gc-MAF, or indirectly by influencing serum levels of vitamin D. It is tempting to speculate that DBP operates as a molecular switch between pro-and anti-inflammation and intervention strategies designed to modify this switch may be important in the control and prevention of chronic and infectious diseases. Nevertheless a precise understanding of the role of DBP in chronic and infectious diseases is still lacking. Correlations between functional DBP variants and adverse health outcomes have been difficult to interpret, in part because there is still much about the biology of DBP that is not well understood. Furthermore, many of the association studies were insufficiently powered and failed to account for multiple comparisons. A greater effort is therefore needed to clarify the relevant gene-gene and gene-environment interactions. Given that GC gene is so polymorphic, it is reasonable to consider that other SNPs in this gene may be more relevant to the disease outcomes being studied, but they have yet to be formally examined. It is becoming clear that DBP is indeed a multifunctional protein with an important auxiliary role in the relationship between vitamin D and innate immunity. The various discordant findings underscore the need for more robust genetic studies and better characterization of just how this protein functions.
